Researchers estimate that if Medicare were to lift the prohibition on coverage of GLP-1s for weight loss alone and institute broad coverage of semaglutide-based products, this could prevent nearly 39,000 cardiovascular events and the program could save over $700 million in net costs over ten years
A.RosChinaM
This means we're desensitized to it, which can lead to type 2 diabetes, cardiovascular disease, metabolic syndrome and more
The SURPASS trials, sponsored by pharmaceutical manufacturer Eli Lilly, assessed Mounjaro (tirzepatide) in people with type 2 diabetes and obesity
People taking these medications are significantly more likely to be diagnosed with mood disorders or experience other mental health issues
250 : : 8254 L-, L-Carnitine, Now Foods, 250 , 60 : 8 2024